Matt Borsch analyst

Currently out of the existing stock ratings of Matt Borsch, 78 are a BUY (57.35%), 55 are a HOLD (40.44%), 3 are a SELL (2.21%).

Matt Borsch

Work Performance Price Targets & Ratings Chart

Analyst Matt Borsch, carries an average stock price target met ratio of 80.61% that have a potential upside of 17.74% achieved within 261 days. Previously, Matt Borsch worked at BMO, GOLDMAN SACHS.

Matt Borsch’s has documented 272 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on MD, Mednax at 10-Aug-2022.

Wall Street Analyst Matt Borsch

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for HCA (HCA HOLDINGS) at 7/13/2020. The price target of $100 was fulfilled within 2 days with a profit of $6.05 (6.44%) receiving and performance score of 32.2.

Average potential price target upside

ACHC Acadia Healthcare Company AMED Amedisys ANTM Anthem CI Cigna Corp CNC Centene Corp CVS CVS Health Corp HCA HCA Holdings HUM Humana MD Mednax MOH Molina Healthcare UHS Universal Health Services UNH UnitedHealth Group WCG WellCare Health Plans EHC Encompass Health Corp ELV Elevance Health AGTI Agiliti AVAH Aveanna Healthcare Holdings ADUS Addus HomeCare ADPT Adaptive Biotechnologies Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Apr-2025

$39

$10.64 (37.52%)

$38

1 months 13 days ago
(30-Jul-2026)

4/7 (57.14%)

$10.86 (38.59%)

135

Hold Since 03-Mar-2026

$32

$3.64 (12.83%)

$25

1 months 13 days ago
(30-Jul-2026)

10/19 (52.63%)

$3.86 (13.72%)

157

Buy Since 07-Jan-2025

$36

$7.64 (26.94%)

$30

1 months 29 days ago
(14-Jul-2026)

3/5 (60%)

$4.4 (13.92%)

37

Buy Since 05-Feb-2025

$40

$11.64 (41.04%)

$25

1 months 29 days ago
(14-Jul-2026)

6/11 (54.55%)

$8.4 (26.58%)

211

Buy Since 31-Jul-2023

$39

$10.64 (37.52%)

$31

2 months 3 days ago
(09-Jul-2026)

5/8 (62.5%)

$7.6 (24.20%)

187

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?